HIGHLIGHTS
- who: Yuxuan Zhang and colleagues from the Zhujiang Hospital, Southern Medical University, Guangzhou, China have published the article: Immortalized Mesenchymal Stem Cells: A Safe Cell Source for Cellular or Cell Membrane-Based Treatment of Glioma, in the Journal: Stem Cells International of 13/04/2022
- what: The authors focused on the safety of immortalized mesenchymal stem cells (im-MSCs) and for the first time studied the feasibility of im-MSCs as candidates for the treatment of glioma.
- how: Specifically hUCMSCs had stronger immunosuppressive ability than imhUCMSCs but the opposite result was obtained in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.